DICICCO WENDY F — SEC Form 4 filings

SEC reporting owner CIK 1225165. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-06.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-01-09 to 2026-01-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
EyePoint, Inc. (EYPT)Director41 leg · 2,567 sh · $19,9973
Akari Therapeutics Plc (AKTX)Interim CFO11

Form 4 filings — DICICCO WENDY F

FiledFormIssuerReported transactionsSource
2026-01-064EyePoint, Inc. (EYPT)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-01-074EyePoint Pharmaceuticals, Inc. (EYPT)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-08-214EyePoint Pharmaceuticals, Inc. (EYPT)Purchase (P): 2,567 @ $7.79EDGAR
2024-05-034Akari Therapeutics Plc (AKTX)Grant/award (A): 158,473,915 @ $0EDGAR
2024-01-094EyePoint Pharmaceuticals, Inc. (EYPT)Grant/award (A): 25,014 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1225165 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →